XML 72 R54.htm IDEA: XBRL DOCUMENT v3.22.0.1
Selected Quarterly Financial Data (unaudited) (Tables)
12 Months Ended
Dec. 31, 2021
Quarterly Financial Information Disclosure [Abstract]  
Summary of Unaudited Quarterly Results
The following table summarizes our unaudited quarterly results for the last two years:

Year ended December 31, 2021First QuarterSecond QuarterThird QuarterFourth QuarterTotal
Revenue (1)(2)
$180.0 $212.8 $199.2 $181.4 $773.4 
(Loss) income from operations (3)
1.9 25.5 12.5 3.7 43.6 
Net (loss) income (4)
(51.7)(0.1)29.3 32.4 9.9 
Earnings (loss) per share of Class A common stock - Basic(0.14)— 0.12 0.13 0.12 
Earnings (loss) per share of Class A common stock - Diluted(0.14)— 0.12 0.13 0.11 
Year ended December 31, 2020First QuarterSecond QuarterThird QuarterFourth QuarterTotal
Revenue (1)(2)
$131.7 $130.7 $154.7 $193.5 $610.6 
(Loss) income from operations(3.6)13.7 (1.7)9.2 17.6 
Net (loss) income(8.9)7.0 (13.3)0.7 (14.5)
Earnings (loss) per share of Class A common stock - Basic (5)
NMNMNMNMNM
Earnings (loss) per share of Class A common stock - Diluted (5)
NMNMNMNMNM
(1)    Historically, there has been a seasonal pattern to our revenue in our Home & Community Services segment with revenues in the fourth quarter of each calendar year generally lower than the other quarters due to fewer IHEs scheduled in the fourth quarter. However, in 2020, the COVID-19 pandemic led to a large number of in-person IHEs being performed in the second half of the year, particularly in the fourth quarter, which resulted in higher revenue during this time period.
(2)    During the second and fourth quarters of 2021, we recorded approximately $9.7 million and ($0.5) million, respectively, in adjustments to estimated revenue in our ECS segment. During the second, third and fourth
quarters of 2020, we recorded $8.9 million, $9.2 million and $13.4 million, respectively, in adjustments to estimated revenue in our ECS segment. See Note 6 Revenue Recognition.
(3) Loss (income) from operations includes an asset impairment of $11.2 million in the fourth quarter 2021 related to the PatientBlox technology intangible asset. See Note 8 Intangible Assets.
(4) Net (loss) income includes $56.8 million, $14.6 million, $(27.3) million and $(36.7) million in remeasurement of the outstanding EARs in each of the first, second, third and fourth quarters of 2021, respectively.
(5) Basic and diluted earnings (loss) per share of Class A common stock is applicable only for the periods subsequent to February 12, 2021, which is the period following the IPO and related Reorganization Transactions.